April 29th 2025
Jon Giles, MD, speaks to the power of personalized medicine and multidisciplinary care to enhance treatment for patients with rheumatoid arthritis (RA).
Dr Milena Murray on Ensuring Ongoing Patient Interactions During the COVID-19 Pandemic
November 5th 2020Partnering with pharmacists ensures prescription availability for patients with HIV during the coronavirus disease 2019 (COVID-19), noted Milena Murray, PharmD, MSc, BCIDP, AAHIVP, of Midwestern University College of Pharmacy.
Watch
Dr Milena Murray on the Importance of Using People-First Language With Patients Living With HIV
October 30th 2020The patients must always come first, emphasized Milena Murray, PharmD, MSc, BCIDP, AAHIVP, associate professor at Midwestern University College of Pharmacy, who practices at the Northwestern Medicine Infectious Disease Center in Chicago.
Watch
Weighing the Pros, Cons of At-Home Use of Biologics for Asthma
October 28th 2020When the first biologic to treat asthma was approved by the FDA in 2003, it needed to be administered subcutaneously in the physician’s office. Now, there are 3 options available for at-home use: mepolizumab, benralizumab, and dupilumab.
Read More
Enthesitis in Psoriatic Arthritis Increases Disease Burden, Decreases Treatment Satisfaction
October 27th 2020Patients with psoriatic arthritis with enthesitis are more likely to have severe disease than patients without enthesitis, and they and their physicians are less likely to be satisfied with their treatments.
Read More
Diagnosing ARDS Earlier and the Development of ICU Delirium in Patients With ARDS
October 21st 2020Abstracts presented at CHEST 2020 looked at improving diagnosis of acute respiratory distress syndrome (ARDS) with machine learning and the development of intensive care unit delirium in hospitalized patients with ARDS.
Read More
Dr J. Allen Meadows on Making the Decision to Put a Patient With Asthma on a Biologic
October 14th 2020Patients with severe asthma are good candidates for biologics, but choosing which biologic requires a shared decision-making conversation, said J. Allen Meadows, MD, president of the American College of Allergy, Asthma & Immunology.
Watch
“Can You Hear Me Now?”: Postoperative Patient-Initiated Communication With Providers
October 14th 2020Patient-provider communication after surgery is critical for patient safety. The growth of patient-provider communication technologies has created opportunities to study postoperative patient-initiated communication.
Read More
Dr John Corboy Forecasts Promising Developments in Multiple Sclerosis
October 13th 2020Rebooting the immune system is an exciting approach, noted John Corboy, MD, professor of neurology, University of Colorado Denver, School of Medicine, and co-director of the Rocky Mountain MS Center at Anschutz Medical Campus.
Watch
Patient-Centered Communication and Outcomes in Heart Failure
Among community patients living with heart failure, excellent and good patient-centered communication was associated with a reduced risk of death.
Read More
Dr J. Allen Meadows Outlines New Long-term Safety, Efficacy Data for Dupilumab in Asthma
October 10th 2020New data on the long-term efficacy and safety of dupilumab are very reassuring to patients with asthma, explained J. Allen Meadows, MD, president of the American College of Allergy, Asthma & Immunology.
Watch
What Factors Will Be Influential to Employer Health Benefit Cost in 2021?
October 8th 2020As employers seek to gain a pulse of what the health care benefit cost trend will be for the coming year, the Business Group on Health will be monitoring several factors, including the impact of the pandemic, efficacy of virtual care, and deferral in care delivery.
Watch
Report Describes Case of SARS-CoV-2 Found in Ocular Tissues of Former COVID-19 Patient
October 8th 2020Researchers found the nucleocapsid protein (NP) antigen of SARS-CoV-2, the virus which causes coronavirus disease 2019 (COVID-19), existed intracellularly in the ocular tissues of a patient who previously had COVID-19.
Read More
Dr Blythe Adamson: Checkpoint Inhibitor Approval Linked to Uptick in Systemic End-of-Life Care
October 8th 2020Blythe Adamson, PhD, MPH, of Flatiron Health, discusses study results she presented at the annual American Society of Clinical Oncology meeting on the use of immune checkpoint inhibitors in end-of-life care
Watch
Addressing Cancer Disparities Requires Asking Questions and Putting Aside Assumptions
September 28th 2020Speakers at Patient-Centered Oncology Care® highlighted injustices in the US health care system, the risk of financial toxicity, and how providers can do a better job to ensure their patients achieve health equity, during a panel discussion.
Read More
Dr Neal Jain on the Real-World Results of Dupilumab in Asthma
September 26th 2020In the real world, dupilumab has been as effective as the results in clinical trials, and patients are seeing low exacerbation rates, emergency department visits, and hospitalizations, explained Neal Jain, MD, FAAP, FAAAAI.
Watch
Comparing Disease Impact and Activity in Psoriatic Arthritis by Ethnic Background
September 23rd 2020Patients of South Asian origins who have psoriatic arthritis have a worse clinical phenotype and worse disease impact than patients of North European origins, according to research published in Rheumatology.
Read More
Phase 2 Trial Shows Weekly Insulin Injection Outcomes Similar to Daily Injections for T2D
September 22nd 2020In individuals with type 2 diabetes with no previous insulin treatment, once-weekly injections of insulin icodec resulted in glucose-lowering efficacy and a safety profile similar to individuals who took once-daily insulin glargine U100.
Read More
Transitioning From Pediatric to Adult Care Is a Vulnerable Time for Patients With Rheumatic Diseases
September 20th 2020Pediatric patients who had a referral from their pediatric rheumatologist and continued insurance coverage saw decreased delays when transitioning to an adult rheumatology clinic.
Read More
Dr Neal Jain Discusses the Use of Dupilumab in Oral Steroid–Dependent Asthma
September 19th 2020Patients who have oral corticosteroid–dependent asthma are recommended to use dupilumab, which reduces the use of oral steroids, explained Neal Jain, MD, FAAP, FAAAAI, of Arizona Allergy & Immunology Research.
Watch
Dr Ruth Ann Marrie Highlights the Impact of Obesity on MS Risk and Treatment Responses
September 14th 2020Obesity is common in the general population and research has shown it can increase the risk of multiple sclerosis (MS), as well as increase diagnostic delays, explained Ruth Ann Marrie, MD, PhD, director of the Multiple Sclerosis Clinic at the University of Manitoba.
Watch
Amy Perrin Ross Outlines the Role of MS Nurses in Diagnosis and Care Management
September 14th 2020Nurses often get involved with patients with multiple sclerosis (MS) before their diagnosis and then work to educate them on the disease and its care, said Amy Perrin Ross, APN, MSN, CNRN, MSCN, Neuroscience Program Coordinator at Loyola University Medical Center.
Watch